Outcomes and Registries Programme

The NHS England Outcomes Registries Programme (ORP) was established in 2022 to develop a single, unified registry solution. This consolidates existing implantable device-level registries and implements new (non-device related) clinical outcome registry data collections to address data and vigilance gaps, enabling the prevention of patient safety issues and adverse outcomes.

Over 2 million patients a year undergo a procedure that includes a high-risk medical device. The programme addresses the need for a more consistent approach to assure safety, enable good outcomes, and fulfils the recommendations of the Independent Medicine and Medical Device Safety Review (IMMDS) (2020) and the Paterson Inquiry (2020).

“A central patient-identifiable database should be created by collecting key details of the implantation of all devices at the time of the operation. This can then be linked to specifically created registers to research and audit the outcomes both in terms of the device safety and patient reported outcomes measures”.

Recommendation 7 of First do no harm, IMMDS Review, 2020, chaired by Baroness Cumberlege.

NHS England has a priority list of new registries to be developed as well as providing a secure stable location for existing at-risk registries that cover a variety of specialisms. Subsequent registry datasets will be linked to or integrated within the solution and have been developed alongside patient reported outcome measures (PROMS) and patient reported experience measures (PREMs).

During 2025/26 the ORP has reached a key milestone in collecting 4 million devices within its Medical Devices Outcome Registry.

These devices come from numerous registries, with the National Major Trauma Registry (NMTR), Breast and Cosmetic Implant Registry (BCIR) and National Registry of Hearing Implants (NRHI) currently linked into the programme to provide data. The Pelvic Organ Prolapse and Stress Urinary Incontinence (POPSUI) Registry, following a successful pilot, is currently rolling out across specialist trusts, with further plans to improve coverage to all trusts and specialities in due course. The National Inflammatory Bowel Disease Registry (NIBDR), which is the first disease registry within the programme is also now live. The NIBDR is the continuation of the UK Inflammatory Bowel Disease (IBD) Registry which started in 2012 as a quality improvement and audit database, before becoming an ethically approved research database in 2022 and adding the delivery of collaborative translational studies that help improve the lives of people with IBD. Work continues to establish the Orthopaedic Trauma Registry (OTR), which is currently piloting and developing a plan to go live.

The programme is also working alongside registries like the National Joint Registry (NJR) and National Vascular Registry (NVR) who undertake their own research and assessment.

In collaboration with the devolved administrations, the programme is also developing an approach to enable secure data sharing, system interoperability and UK-wide coverage, where it is appropriate to do so. 

The Medical Devices Outcome Registry

The Medical Devices Outcome Registry (MDOR) was established as the data collection for implantable device data. MDOR takes data from different collections to create a single unified view of implantable devices and associated outcomes.

Where no current registry exists, data can also be submitted to MDOR directly. Work is ongoing with trusts to establish these direct submissions, with the aim of engaging with all healthcare providers, systems and major independent sector healthcare providers, with at least 90% of NHS providers submitting by 30 April 2026.

Data publications

The ORP has a commitment to make available a number of publications to demonstrate the programme’s progress. This includes a twice-yearly publication detailing provider level engagement with the MDOR as part of the legal directive for the collection of data (Outcomes and Registries Directions 2024 – NHS England Digital).

The most recent of these publications was made available in February 2026. This publication provides details of those providers who were in a position to engage with the programme by 31 December 2025, as well as their current stage of engagement. The focus on this publication relates to contributions received to the MDOR.

The most recent publication indicates approximately 2.6 million implanted medical devices recorded on the registry by 31 December 2025

Previous publications can be found on the MDOR statistics page.

If you are a provider who has not yet engaged with the programme but would like to work towards submitting data, please email  england.mdor.outcomesandregistries@nhs.net

What is an outcome registry?

Outcome registries are organised systems that use observational methods to collect routine, uniform data on specified outcomes in a population defined by a particular disease, condition, or exposure. Important features of registries include:

  • collection of high-quality, high-volume patient, practice and population-level data
  • development input and expertise from clinical leadership
  • availability of enriched, comparative data for multiple upstream patient safety and quality improvement purposes
  • timely feedback of data to inform clinical decision-making

Outcome registries can often be confused with clinical audits that measure care against explicit audit criteria as part of a quality improvement cycle. Data is collected less frequently in audits and often with lower levels of data granularity than in routine registry data collections.

What will the benefit be to patients?

The fundamental purpose of the ORP is to capture data from NHS and private healthcare providers to detect and predict issues relating to patient safety and outcomes and prevent harm to future patients. The registry will also:

  • maximise data for surveillance, benchmarking and recall activities
  • increase transparency and accountability
  • enhance research and development
  • reduce costs of participation

Accurate data that is routinely collected at the point of care and linked to patient outcomes will allow stakeholders to turn intelligence into actionable improvements. The data will enable organisations to:

  • help identify patients who have received specific implants that are subsequently performing poorly
  • determine how long different types of implants last
  • empower patients by helping them find out more about the devices available to them
  • help surgeons choose the best devices for their patients
  • improve patient safety by monitoring how well implants, surgeons and hospitals perform and take action where necessary
  • give hospitals, surgeons and implant manufacturers feedback about their performance to help them improve patient care
  • invite patients to take part in feedback activities about their surgery, so that patient outcomes, experience and satisfaction can be assessed and monitored

If you have any questions, please email england.support.outcomeregistries@nhs.net

If you are a provider who has not yet engaged with the programme but would like to work towards submitting data, please email england.mdor.outcomesandregistries@nhs.net